However, for AChE, although there is no direct evidence of AChE expression in AP, we found that in a targeted drug study on hepatocellular carcinoma by Wang K et al. [17], they found that elevated AChE as a therapeutic target could effectively improve the progression of hepatocellular carcinoma. Here, ACHE is linked to hepatocellular carcinoma.